Cancer Drug Avastin Linked to Death Risk
Feb. 1, 2011 -- Patients treated with Avastin, a top-selling cancer medication, appear to have a 50% increased risk of dying from treatment-related adverse events compared to the use of chemotherapy alone, a new research review finds.
What’s more, the risk of fatal problems like bleeding, blood clots, and bowel perforations may more than triple when the biologic therapy Avastin is used
No comments:
Post a Comment